Ray Manneh Kopp

10PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer diagnosisPacific Peoples health policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 12, 2026
A REtrospective Study to Describe the Real-World Treatment Landscape in Patients with Metastatic Castration-Resistant PROstate Cancer: REMPRO.

Ray Manneh, Tarek Hashem, Joung Jae Young

|Oct 29, 2025
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.

Francesco Massari, Matteo Rosellini, Bohuslav Melichar

|Mar 05, 2025
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.

Daniel P Petrylak, Raffaele Ratta, Nobuaki Matsubara

|Sep 30, 2024
Genomic Landscape in Prostate Cancer in a Latin American Population.

Martín Angel, Berenice Freile, Andres Rodriguez

|Jul 16, 2024
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer

Marc E Pierre, Ray Manneh, Abraham Hernández

|May 15, 2024
Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches.

Ray Manneh, Carmen Alaez Verson, Angel Martin

Pageof 2

Frequent Collaborators

3 joint publications

Maria Teresa Bourlon

2 joint publications

Felipe Moraes Toledo Pereira

2 joint publications

Laura Bernal Vaca

2 joint publications

Silvia Patricia Neciosup